Found: 5
Select item for more details and to access through your institution.
Solute Carrier Family 29A1 Mediates In Vitro Resistance to Azacitidine in Acute Myeloid Leukemia Cell Lines.
- Published in:
- International Journal of Molecular Sciences, 2023, v. 24, n. 4, p. 3553, doi. 10.3390/ijms24043553
- By:
- Publication type:
- Article
Case report: Rare case of donor cell‐derived T‐cell acute lymphoblastic leukaemia in a female patient after receiving an allo‐transplant from her male sibling.
- Published in:
- British Journal of Haematology, 2023, v. 203, n. 2, p. 282, doi. 10.1111/bjh.19008
- By:
- Publication type:
- Article
A Personalized Risk Model for Azacitidine Outcome in Myelodysplastic Syndrome and Other Myeloid Neoplasms Identified by Machine Learning Model Utilizing Real-World Data.
- Published in:
- Cancers, 2023, v. 15, n. 16, p. 4019, doi. 10.3390/cancers15164019
- By:
- Publication type:
- Article
CBL mutations in chronic myelomonocytic leukemia often occur in the RING domain with multiple subclones per patient: Implications for targeting.
- Published in:
- PLoS ONE, 2024, v. 19, n. 9, p. 1, doi. 10.1371/journal.pone.0310641
- By:
- Publication type:
- Article
Dynamic assessment of RBC-transfusion dependency improves the prognostic value of the revised-IPSS in MDS patients.
- Published in:
- American Journal of Hematology, 2017, v. 92, n. 6, p. 508, doi. 10.1002/ajh.24704
- By:
- Publication type:
- Article